ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 387.7 | 376.6 | 137.7 |
| Other income | 3.8 | 10.1 | 7.7 |
| Total income | 391.4 | 386.7 | 145.4 |
| Profit before exceptional items & tax | 57.0 | 64.7 | 35.4 |
| Profit before tax | 57.0 | 64.7 | 35.4 |
| Net profit | 44.5 | 48.2 | 26.1 |
| Operating margin | 14.6% | 16.7% | 24.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +70.50% |
|---|---|
| Net profit, quarter on quarter | -7.70% |
| Revenue, year on year | +181.60% |
| Operating profit, year on year | +92.10% |
| Operating profit, quarter on quarter | -2.60% |
BSE results filing, NSE: FCL. Figures extracted from the filing.
Fineotex Chemical Ltd: key numbers
- Share price
- ₹53.17
- Market cap
- ₹6,192 Cr
- Revenue (annual)
- ₹772.2 Cr
- Net profit (annual)
- ₹108.8 Cr
- P/E (TTM)
- 50.6×Sector 35.1×
- Promoter holding
- 62.30%+0.00% QoQ
- FII holding
- 2.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fineotex Chemical Ltd
All →Fineotex Chemical Board Meeting Date
Fineotex Chemical Ltd has scheduled a board meeting on November 13, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new US-based subsidiary, Fineotex America Inc., for ₹0.05 Crore to provide specialized water treatment solutions.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical's FZE subsidiary incorporated Fineotex America Inc. in Delaware, USA. The entity will supply water treatment chemicals for data centers and semiconductors.
Fineotex Chemical Annual General Meeting
Fineotex Chemical Limited conducted its 23rd Annual General Meeting on September 11, 2026. Shareholders discussed ordinary and special business items, including dividend and fund raising proposals.
Fineotex Chemical Merger & Restructuring Worth ₹0.05 Cr
Fineotex Chemical's subsidiary, Fineotex Biotex HealthGuard FZE, incorporated a new wholly-owned subsidiary, Fineotex Holdings Inc., in the USA for specialty chemical business activities.
- Value
- ₹0.05 Cr
Fineotex Chemical Merger & Restructuring
Fineotex Chemical Limited incorporated a new wholly-owned step-down subsidiary, Fineotex Holdings Inc., in the USA. This entity will pursue specialty chemical and growth opportunities.